Transthoracic Parametric Doppler – TPD
A New Non-Invasive Tool for Diagnosis of Heart and Lung Disease
Home Technology and Products About EchoSense Contact Us
 

EchoSense Ltd. of Haifa Israel is a medical device company that develops and commercializes non-invasive tools for diagnosis and monitoring of patients suffering from cardiac and pulmonary diseases.

EchoSense was established in 2005 by Prof. Yoram Palti. It is currently conducting clinical trials with the TPD (Transthoracic Parametric Doppler) device in major Medical Centers in Haifa, Israel and New York. EchoSense is based adjacent to MATAM - Advanced Technology Park, Haifa, Israel.

Management

Prof. Yoram Palti, MD, Ph.D.

Founder

Yoram Palti is a professor (emeritus) of Physiology & Biophysics and Biomedical Engineering at the Technion – Israel Institute of Technology. He served as the head of the Rappaport Institute for Research in the Medical Sciences, the medical research arm of the Technion for 12 years. In the past 20 years he founded and managed companies dedicated to development of medical equipment including NovoCure & Carmel Biosensor.

Mr. Lennart Perlhagen

Founder & Chairman of the Board

Lennart Perlhagen is an active entrepreneur and investor in emerging healthcare companies and was the founding investor in NovoCure. Mr. Perlhagen previously founded Meda AB, (public in Sweden), a leading specialty pharmaceutical company that grew from a market capitalization of $10 million to over $4.0 billion during his tenure with the company. Prior to Meda AB, Lennart was the CEO for Scandinavia and UK for Pharmitalia Spa(later acquired by Pfizer)where he gained extensive experience in oncology through the launch of the chemotherapy agent doxorubicin (Adriamycin). Outside oncology, Lennart helped lead the commercial launch of omeprazole (Losec/ Prilosec), which became the best selling pharmaceutical product in the world for Astra AB where he served as Regional Director for South Europe and as a member of the International Marketing strategy Group.

Dr. Rachel Schatzberger, Ph.D.

Chief Scientific Officer

Dr. Schatzberger served as a Researcher first at Stanford and then at the Technion – Israel Institute of Technology for 15 years. In 1992 she joined the Medical Device industry (NovoCure & Carmel Biosensors) as a Research Manager and Regulatory expert. She Joined EchoSense in 2007.

Dr. Dan Weiler, MD

Clinical Director

Dr. Weiler is a well known expert in Internal Medicine and Pulmonology. He headed the regional Pulmonary Function Test Lab in Northern Israel and headed the Carmel Hospital Pulmonary Department and laboratories for many years.

Dr. Rami Unterman, MD

Chief Medical Officer

Dr. Unterman is an internal medicine specialist, experienced in clinical practice and research. Prior to joining EchoSense, he worked as a senior physician at the Sheba Medical Center and gained experience in conducting clinical trials, including ones with medical devices companies. He also served as a medical officer in the Israel Defense Forces, holding various commanding and managerial positions.

Yossi Cohen, MBA, M.Sc.

Chief Technology Officer

Yossi Cohen joined EchoSense in 2012 having 20 years of experience in R&D management and technology leading. Prior to joining EchoSense, Yossi served as a Sr. Director of the TV Communication technology at Zoran Corporation, VP of System Engineering at Oren Semiconductor, Research fellow at IBM Research Lab and in Project Management positions in IDF. Yossi holds an M.Sc. degree in Electrical Engineering from the Technion, Israel Institute of Technology.